ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
First-line icotinib in elderly patients with non-small cell lung cancer harboring active EGFR mutation: A multi-center, single-arm study.
Journal of Clinical Oncology
◽
10.1200/jco.2016.34.15_suppl.e20519
◽
2016
◽
Vol 34
(15_suppl)
◽
pp. e20519-e20519
Author(s):
Chunlei Shi
◽
Aiqin Gu
◽
Liwen Xiong
◽
Yuping LI
◽
Xiaohong Cai
◽
...
Keyword(s):
Lung Cancer
◽
Elderly Patients
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Egfr Mutation
◽
Small Cell
◽
Small Cell Lung
◽
First Line
Download Full-text
Related Documents
Cited By
References
First-line gefitinib therapy for elderly patients with non-small cell lung cancer harboring EGFR mutation: Central Japan Lung Study Group 0901
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-014-2548-z
◽
2014
◽
Vol 74
(4)
◽
pp. 721-727
◽
Cited By ~ 21
Author(s):
Kosuke Takahashi
◽
Hiroshi Saito
◽
Yoshinori Hasegawa
◽
Masahiko Ando
◽
Masashi Yamamoto
◽
...
Keyword(s):
Lung Cancer
◽
Elderly Patients
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Egfr Mutation
◽
Small Cell
◽
Study Group
◽
Small Cell Lung
◽
First Line
◽
Central Japan
Download Full-text
Faculty Opinions recommendation of Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717964584.793468557
◽
2013
◽
Author(s):
Bruno Andreoni
◽
Gianmarco Contino
Keyword(s):
Lung Cancer
◽
Elderly Patients
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
Safety And Efficacy
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Cost-Effectiveness Analysis of Afatinib, Erlotinib, and Gefitinib as First-Line Treatments for EGFR Mutation-Positive Non-Small-Cell Lung Cancer in Ontario, Canada
PharmacoEconomics
◽
10.1007/s40273-021-01022-9
◽
2021
◽
Author(s):
Yong-Jin Kim
◽
Mark Oremus
◽
Helen H. Chen
◽
Thomas McFarlane
◽
Danielle Fearon
◽
...
Keyword(s):
Lung Cancer
◽
Cost Effectiveness
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Egfr Mutation
◽
Cost Effectiveness Analysis
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
Effectiveness Analysis
Download Full-text
Clinical effect of erlotinib as first-line treatment for Asian elderly patients with advanced non-small-cell lung cancer
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-010-1450-6
◽
2010
◽
Vol 67
(2)
◽
pp. 475-479
◽
Cited By ~ 8
Author(s):
Xin-Hua Xu
◽
Jin Su
◽
Xiang-Yang Fu
◽
Feng Xue
◽
Qiao Huang
◽
...
Keyword(s):
Lung Cancer
◽
Elderly Patients
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Clinical Effect
◽
Small Cell
◽
Line Treatment
◽
Small Cell Lung
◽
First Line
◽
First Line Treatment
Download Full-text
Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial
The Lancet Oncology
◽
10.1016/s1470-2045(15)00121-7
◽
2015
◽
Vol 16
(8)
◽
pp. 990-998
◽
Cited By ~ 197
Author(s):
Jean-Charles Soria
◽
Yi-Long Wu
◽
Kazuhiko Nakagawa
◽
Sang-We Kim
◽
Jin-Ji Yang
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Egfr Mutation
◽
Randomised Trial
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
Phase 3
Download Full-text
First-line onartuzumab plus erlotinib treatment for patients with MET-positive and EGFR mutation-positive non-small-cell lung cancer
Cancer Treatment and Research Communications
◽
10.1016/j.ctarc.2018.10.004
◽
2019
◽
Vol 18
◽
pp. 100113
◽
Cited By ~ 4
Author(s):
Kazuma Kishi
◽
Hiroshi Sakai
◽
Takashi Seto
◽
Toshiyuki Kozuki
◽
Makoto Nishio
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Egfr Mutation
◽
Small Cell
◽
Small Cell Lung
◽
First Line
Download Full-text
Correlation between EGFR mutation status and response to first-line platinum-based chemotherapy in patients with advanced non-small cell lung cancer
OncoTargets and Therapy
◽
10.2147/ott.s63665
◽
2014
◽
pp. 1185
◽
Cited By ~ 2
Author(s):
Zhehai Wang
◽
Shu Fang
◽
Jun Guo
◽
Jie Liu
◽
Changzheng Li
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Egfr Mutation
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
Mutation Status
◽
Platinum Based Chemotherapy
Download Full-text
1325 A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients (75-years-old) with advanced non-squamous, non-small cell lung cancer
European Journal of Cancer
◽
10.1016/s0959-8049(16)30568-8
◽
2015
◽
Vol 51
◽
pp. S196
Author(s):
M. Tamiya
◽
A. Tamiya
◽
H. Kaneda
◽
K. Nakagawa
◽
K. Goto
◽
...
Keyword(s):
Lung Cancer
◽
Elderly Patients
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Study
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
Line Chemotherapy
Download Full-text
Pharmacokinetic and pharmacogenomic analysis of low-dose afatinib treatment in elderly patients with EGFR mutation-positive non–small cell lung cancer
European Journal of Cancer
◽
10.1016/j.ejca.2021.10.024
◽
2021
◽
Author(s):
Hidenori Mizugaki
◽
Satoshi Oizumi
◽
Yuka Fujita
◽
Toshiyuki Harada
◽
Yoshiro Nakahara
◽
...
Keyword(s):
Lung Cancer
◽
Elderly Patients
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Low Dose
◽
Egfr Mutation
◽
Small Cell
◽
Small Cell Lung
Download Full-text
First-line therapy of advanced non-small cell lung cancer not harboring an activating EGFR mutation
Lung Cancer Therapy Annual 7
◽
10.3109/9781841848679.006
◽
2012
◽
pp. 59-74
Author(s):
Cesare Gridelli
◽
Antonio Rossi
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Egfr Mutation
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
Activating Egfr Mutation
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close